B2DB — Who said what, where, and when

Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights - Remon Van Geel

ELRIG Drug Discovery 2026 · 14 October 2026 · 12:20–12:50 · Auditorium 3

Lonza’s GlycoConnect® Technology for Best-in-Class ADCs: Emerging Clinical Insights - Remon Van Geel was a session at ELRIG Drug Discovery 2026 on 14 October 2026 in London, with 1 speaker on record.

Speakers